Our CEO, Dr. Doug Dellinger, will be attending the NIH RNA Cancer Biomarkers conference! If you'll be there too, we'd love to connect. Come find us and chat about how Cirena's long RNA synthesis technology can support your biomarker research and discovery pipeline.